AMAG Scrapes New 52-Week Low - TheStreet.com PDF Print
TheStreet.com... for end-stage-renal-disease, or ESRD, patients. The firm brought down its projections for US sales of Feraheme by 28%-41% for the 2011-2014 time period.

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.